Ji Young Lee, MD
Pulmonary Disease · Mobile, ALNPI 1235461930
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Actelion Pharmaceuticals US, Inc. at 30.9% of the total. Reporting peaked in 2021 at $141 and has fallen 82.6% since, to $25 in 2025. That places this record below the midpoint for pulmonary disease clinicians in AL, where the typical reported total is $3,082.
Across 26 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$152
- Bayer$64
- Mallinckrodt Hospital Products Inc.$60
- Merck$53
- United Therapeutics Corporation$51
- Johnson & Johnson$31
- plus $81 from 5 others
What the payments were for
- Food & beverage$490100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 7 | $152 |
| Bayer | 4 | $64 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| Merck | 3 | $53 |
| United Therapeutics Corporation | 3 | $51 |
| Johnson & Johnson | 2 | $31 |
| Inogen, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Sandoz | 1 | $12 |
How this compares
$490 in reported general payments places this provider in the 20th percentile of 215 pulmonary disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Mobile
- Adrian DivittorioMobile$100K
- Peter LutzMobile$63K
- Virginia RadcliffMobile$23K
- Johnson HaynesMobile$21K
- Cynthia CrowderMobile$20K
- Philip AlmaloufMobile$14K
- Campbell SindelMobile$14K
- Chibuzo OdigweMobile$14K
- Caesar AgaganMobile$11K
- James DeanMobile$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.